Atlas Trials

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Clinical trial NCT06371274 · RECRUITING

Trial details

NCT number
NCT06371274
Sponsor
First Affiliated Hospital of Zhejiang University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Triple-negative Breast Cancer
Start date
2024-10-10
Primary completion
2026-04-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.